Developing treatments for rare diseases involves more than scientific discovery. Pharmaceutical companies must also address manufacturing capacity, regulatory approval, reimbursement, distribution, and patient access. These factors are especially important for conditions such as Gaucher disease, where specialized therapies and ongoing monitoring may be required.
The Gaucher Disease Market...
